This article synthesizes peer-reviewed research on GHK-Cus biological activity and its rapidly expanding applications in clinical aesthetics
In controlled research environments, it is studied for its involvement in receptor-mediated signaling, peptide-regulated cellular activity, and tissue-focused biochemical models
Deficiency is widespread in the UK due to limited sunlight exposure, and is particularly prevalent in those with chronic illness, darker skin tones, or conditions affecting fat absorption
Administered as a subcutaneous injection five mornings per week, Recovery Blend is designed for patients recovering from surgery, injury, or chronic inflammation, as well as those supporting long-term joint, skin, and gut health
Boosting collagen production: The peptide activates fibroblasts, the cells responsible for producing collagen, the structural protein that forms the scaffold of tendons, ligaments, and other connective tissues
Adverse effects are rare and mild